Sumagan, Baby Boy .
HRN: 27-01-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2025
AMPICILLIN 250MG (VIAL)
04/20/2025
04/27/2025
IV
145mg
Q12
T/C MAS
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes